Weekly schedule of vinorelbine in pretreated breast cancer patients

Cecilia Nisticò,Carlo Garufi,Michele Milella,Angela Vaccaro,A.M. DOttavio,Alessandra Fabi,Andrea Pace,Loredana Bove,Francesco Tropea,Annelisa Marsella,Fiorentino Izzo,Rita Maria D'Attino,Virginia Ferraresi,Salvatore Delella Marco,E. Terzoli

Weekly schedule of vinorelbine in pretreated breast cancer patients

2000

Cecilia Nisticò
Carlo Garufi
Michele Milella
Angela Vaccaro
A.M. DOttavio
Alessandra Fabi
Andrea Pace
Loredana Bove
Francesco Tropea
Annelisa Marsella
Fiorentino Izzo
Rita Maria D'Attino
Virginia Ferraresi
Salvatore Delella Marco
E. Terzoli

Purpose: In this phase II study, we explored tolerability and activity of vinorelbine administered according to a dose-dense weekly schedule with hematopoietic growth factor support in pretreated, advanced breast cancer patients.

Keywords:

Cancer research
Breast cancer
Vinorelbine
Hematopoietic growth factor
Growth factor
Tolerability
Medicine
Oncology
dose intensity
Phases of clinical research
Cancer
Internal medicine
advanced breast

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations